The U.S. Justice Department has launched a criminal investigation into Eli Lilly and Co (LLY.N) focused on alleged manufacturing irregularities and records tampering at a factory in Branchburg, New Jersey, that produces the pharmaceutical giant’s COVID-19 therapy and other drugs, three people familiar with the matter said. Read More
EXCLUSIVE U.S. opens criminal probe into alleged lapses at Eli Lilly plant
2021-05-27T16:06:35-04:00May 27th, 2021|
Related Posts
-
4 Stocks to Play India’s Election, Go to article
May 22nd, 2024